Advertisement
Research Article| Volume 49, ISSUE 3, P205-210, November 15, 2004

Download started.

Ok

Relationship between psychological complaints and vasomotor symptoms during climacteric

      Abstract

      Background: It has been suggested that hormonal changes and environmental alterations during the climacteric period are important in the development of psychological symptoms. Objective: To evaluate the role of biological and psycho-social factors in the prevalence of climacteric symptoms. Design: Open, cross-sectional, observational and descriptive study. Material and methods: A total of 300 women between 40 and 59 years of age were evaluated using Greene scale for climacteric symptoms, Cooper questionnaire for psychosomatic symptoms of stress, Smilkstein family apgar for family dysfunction, Duke-UNC questionnaire for social support and Israel scale for vital events. All these tests have been previously validated in Spanish. Results: Postmenopausal women do not have higher prevalence of psychological symptoms, they only have more vasomotor symptoms. Premenopausal women with vasomotor symptoms have more psychological and somatic symptoms and stress, independently of the vital events, family dysfunction or poor social support. Vasomotor symptoms in the premenopause are associated with increased risk of anxiety (OR: 3.7, IC: 1.4–9.7; P<0.008), depression (OR: 8.1, IC: 2.5–26.4; P<0.0005), somatic symptoms (OR: 14.9, IC: 3.4–65.3; P<0.0003), sexual dysfunction (OR: 7.2, IC: 2.5–20.6; P<0.0002) and stress (OR: 7.5, IC: 3.5–15.9; P<0.0001). Negative vital events and family dysfunction increase in minor intensity the risk of anxiety, depression and stress. Conclusion: In conclusion, psychological symptoms are frequent in the premenopause and are associated to vasomotor symptoms. This observation links psychological symptoms with menopausal transition and might suggest an organic base in their origin. The negative psycho-social environment is a factor that favours the development of these symptoms.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Blümel J.E.
        • Roncagliolo M.E.
        • Gramegna G.
        • Tacla X.
        • Sepulveda H.
        Prevalencia de sı́ntomas psı́quicos y vasomotores en diferentes periodos del Climaterio.
        Rev. Chil. Obstet. Ginecol. 1997; 62: 412-418
        • Harlow B.L.
        Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Havard Study of Moods and Cycles.
        Arch. Gen. Psychiatry. 2003; 60: 29-36
        • Zichella L.
        The importance of life style after menopause.
        Int. J. Fertil. Menopausal Stud. 1995; 40: 9-15
        • Dennerstein L.
        • Smith A.M.
        • Morse C.
        Psychological well-being.
        Maturitas. 1994; 20: 1-11
        • Collins A.
        • Landgren B.M.
        Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study.
        Maturitas. 1994; 20: 101-111
        • Menditto A.
        • Cassese E.
        • Balbi C.
        Climacteric and quality of life.
        Minerva Ginecol. 1999; 51: 83-89
        • Avis N.E.
        • Crawford S.L.
        • McKinlay S.M.
        Psychosocial, behavioral, and health factors related to menopause symptomatology.
        Womens Health. 1997; 3: 103-120
        • Blümel J.E.
        • Castelo-Branco C.
        • Binfa L.
        • Gramegna G.
        • Tacla X.
        • Aracena B.
        • et al.
        Quality of life after the menopause: a population study.
        Maturitas. 2000; 34: 17-23
        • Blümel J.E.
        • Castelo-Branco C.
        • Binfa L.
        • Aparicio R.
        • Mamani L.
        A scheme of combined oral contraceptives for women more than 40 years old.
        Menopause. 2001; 8: 286-289
        • Greene J.G.
        Constructing a standard climacteric scale.
        Maturitas. 1998; 29: 25-31
      1. Cooper C. The stress check. Englewood Cliffs, NJ: Prentice-Hall (Spectrum); 1981.

        • Trucco M.
        • Valenzuela P.
        • Trucco D.
        Occupational stress in health care personnel.
        Rev. Med. Chil. 1999; 127: 1453-1461
        • Smilkstein G.
        The family apgar: a proposal of a family function test and its use by physicians.
        J. Fam. Pract. 1978; 6: 1231-1239
        • Bellon Saameño J.A.
        • Delgado Sanchez A.
        • Luna del Castillo J.D.
        • Lardelli Claret P.
        Validity and reliability of the family apgar family function test.
        Aten Primaria. 1996; 18: 289-296
        • Broadhead W.E.
        • Gehlbach S.H.
        • De Gruy F.W.
        • Kaplan B.H.
        The Duke-UNC functional social support questionnaire. Measurement of social support in family medicine patients.
        Med. Care. 1988; 26: 709-723
        • De la revilla L.
        • Bailón J.
        • De Dios J.
        • Delgado A.
        • Prados M.
        • Felitas L.
        Validation of a functional social support scale for use in the family doctor’s office.
        Atenciòn Primaria. 1991; 8: 688-692
        • Israel B.A.
        • Schurman S.J.
        • Heaney C.A.
        • Mero R.P.
        The relation of personal resources, participation, influence, interpersonal relationships and coping strategies to occupational stress, job strains and health: a multivariate analysis.
        Work Stress. 1989; 3: 163-194
      2. Brett KM, Chong Y. Hormone replacement therapy: knowledge and use in the states unites. Hyattsville, MD: National Canter for Health Statistics; 2001.

        • Brown W.J.
        • Mishra G.D.
        • Dobson A.
        Changes in physical symptoms during the menopause transition.
        Int. J. Behav. Med. 2002; 9: 53-67
        • Kuh D.
        • Hardy R.
        • Rodgers B.
        • Wadsworth M.E.
        Lifetime risk factors for women’s psychological distress in midlife.
        Soc. Sci. Med. 2002; 55: 1957-1973
        • Dennerstein L.
        • Smith A.M.
        • Morse C.
        Psychological well-being, mid-life and the menopause.
        Maturitas. 1994; 20: 1-11
        • Hardy R.
        • Kuh D.
        Change in psychological and vasomotor symptom reporting during the menopause.
        Soc. Sci. Med. 2002; 55: 1975-1988
        • Porter M.
        • Penney G.C.
        • Russell D.
        • Russell E.
        • Templeton A.
        A population based survey of women’s experience of the menopause.
        Br. J. Obstet. Gynaecol. 1996; 103: 1025-1028
        • Olofsson A.S.
        • Collins A.
        Psychosocial factors.
        Climacteric. 2000; 3: 33-42
        • Vanwesenbeeck I.
        • Vennix P.
        • van de Wiel H.
        Menopausal symptoms: associations with menopausal status and psychosocial factors.
        J. Psychosom. Obstet. Gynaecol. 2001; 22: 149-158
        • Joffe H.
        Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care.
        Menopause. 2002; 9: 392-398
        • Berendsen H.H.
        The role of serotonin in hot flushes.
        Maturitas. 2000; 36: 155-164
        • Lu N.Z.
        • Eshleman A.J.
        • Janowsky T.O.
        • Bethea C.L.
        Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.
        Mol. Psychiatry. 2003; 8: 353-360
        • Loprinzi C.L.
        • Kugler J.W.
        • Sloan J.A.
        • Mailliard J.A.
        • LaVasseur B.I.
        • Barton D.L.
        • et al.
        Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
        Lancet. 2000; 356: 2059-2063